Store-operated Ca 2+ entry (SOCE) is typically activated after the depletion of endoplasmic/sarcoplasmic reticulum (ER/SR) Ca 2+ stores and mediates Ca 2+ influx across the plasma membrane to replenish the depleted stores. 1 This Ca 2+ entry mechanism is widely distributed in diverse cell types, including electrically non-excitable and excitable cells, and plays a role in various cellular processes such as gene transcription, cell proliferation, enzyme control, and apoptosis, depending on cell type. A number of studies have suggested that the putative SOCE channels are closely related to the transient receptor potential canonical (TRPC) gene family that comprises seven isoforms (TRPC1-7). 2 -4 Although it appears that SOCE is not fundamentally involved in Ca 2+ loading into the SR in the adult heart under physiological conditions, 5 recent studies have indicated that SOCE, TRPC channels, or both are responsible for abnormal Ca 2+ handling under some pathophysiological conditions in the heart. For example, the expression of TRPC1, TRPC3, and/or TRPC6 is elevated and mediates a cardiac hypertrophic response to pressure overload in experimental animal models. 5 -8 On the other hand, the up-regulation of TRPC5 has been detected in failing human heart. 9 Our previous experiments provide evidence to suggest that TRPC channels mediate the Ca 2+ entry responsible for the Ca 2+ paradox-mediated Ca 2+ overload in mouse ventricular myocytes. 10 11 In addition, recent studies have demonstrated an important observation that the Ca 2+ influx associated with SOCE contributes to intracellular Ca 2+ overload with resultant cellular injury in the heart during ischaemia/reperfusion. associated with intracellular and mitochondrial Ca 2+ overload, which appears to be one of the main mechanisms mediating the cardioprotective effects of these agents against ischaemia/reperfusion injury. 14 -18 However, the precise ionic mechanisms involved in the preventive effects of sevoflurane on cellular Ca 2+ loading are not fully elucidated. The present study was designed to address the question of whether sevoflurane has an inhibitory effect on SOCE activity in cardiac ventricular myocytes.
Methods

Isolation of mouse ventricular myocytes
The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and all protocols were approved by the institution's Animal Care and Use Committee (2010-1-3, 2010-1-3H). Ventricular myocytes were enzymatically dissociated from the heart of 7-to 12-week-old male C57BL/6J mice (20-25 g body weight) killed with an overdose of sodium pentobarbital (300 mg kg 21 , i.p.) with heparin (8000 units kg 21 ), as described previously. 10 11 19 Solutions and chemicals
Normal Tyrode solution contained (in mM) 140 NaCl, 5. were continuously present thereafter (Fig. 1A) . This combined application of thapsigargin and angiotensin II to the Ca 2+ -free medium was previously shown to be effective at causing Ca 2+ store depletion leading to the activation of SOCE in rat ventricular myocytes. 22 The SOCE was assessed by measuring the increase in cytosolic Ca 2+ levels upon return to the normal Tyrode solution. When used, verapamil, KB-R7943, 2-APB, or sevoflurane was added to the bathing solutions throughout the experiments (Fig. 1B ). 2-APB has proven to be a reliable blocker of SOCE while it also blocks IP 3 -induced Ca 2+ release from the ER/SR but with less potency. 21 23 KB-R7943 at 5 mM has been reported to substantially block the Na + /Ca 2+ exchange (NCX) current but has little effect on the cytosolic Ca 2+ elevation associated with SOCE in cardiac ventricular myocytes. 8 22 24 25 The fluo-3 fluorescence intensity (F ), which was used to estimate the cytosolic Ca 2+ levels, was normalized to the baseline value (F base ) measured just before adding thapsigargin and angiotensin II to the nominally Ca 2+ -free Tyrode solution, and F/F base was reported as a function of the time that elapsed from starting the Ca 2+ -free superfusion. These fluorescence data were provided from the time point at which thapsigargin and angiotensin II were added to the nominally Ca 2+ -free Tyrode solution, and the data during the last 2 min of superfusion with normal Tyrode solution were omitted.
In some experiments, the fluo-3-loaded ventricular myocytes were similarly superfused (as shown in Fig. 1A ) but without the addition of thapsigargin and angiotensin II. The fluo-3 fluorescence Ca 2+ measurements were also conducted during continuous superfusion with normal Tyrode solution with and without the addition of thapsigargin and angiotensin II.
Superfusion protocol for mag-fluo-4 fluorescence measurement
Mag-fluo-4-loaded ventricular myocytes were successively superfused with normal Tyrode and nominally Ca 2+ -free Tyrode solutions in a protocol similar to that used for fluo-3 fluorescence measurements, with and without the addition of thapsigargin and angiotensin II (refer to Fig. 1A ). The mag-fluo-4 fluorescence intensity (mag-fluo-4 F ), which has proven to be useful for assessing the SR Ca 2+ levels in ventricular myocytes, 11 22 26 was normalized to the baseline value (mag-fluo-4 F 0 ) measured just after starting Ca 2+ -free superfusion and was provided as the mag-fluo-4 F/F 0 for the period of Ca 2+ -free superfusion.
Whole-cell patch-clamp recordings
Whole-cell membrane currents 27 were recorded using an EPC-8 patch-clamp amplifier (HEKA, Lambrecht, Germany) from isolated mouse ventricular myocytes superfused at 34-368C in a recoding chamber (0.5 ml in volume) mounted on the stage of an inverted microscope (TMD-300, Nikon). Fire-polished pipettes pulled from borosilicate glass capillaries (Narishige Scientific Instrument Lab., Tokyo, Japan) had a resistance of 2.0 -3.5 MV when filled with the patch-pipette solution. Membrane currents were recorded during the voltage-ramp protocol (dV/dt¼ +0.25 V s 21 ), which consisted of three phases: an initial +50 mV depolarizing phase from a holding potential of 0 mV, a second hyperpolarizing phase of 2150 mV, and then a third phase returning to the holding potential of 0 mV. The currentvoltage (I-V ) relationship was measured during the second hyperpolarizing phase, and the current amplitude was presented as current density (in pA pF 21 ). All potentials were offline corrected for a liquid junction potential of 10 mV between the aspartate-rich patch-pipette solution and bath solutions. Changes in SOCE current activation were evaluated from a linear least-squares fit to the I-V relationships at potentials within a 20 mV range centred on the reversal potential ( 0 mV). In the present whole-cell patch-clamp experiments, the internal Ca 2+ level was clamped to 0.1 mM 28 29 by using a high concentration (5 mM) of the Ca 2+ chelator EGTA, which is the standard method for assessing SOCE activity by whole-cell recording. 21 30 31 Statistical analysis
The sample size was calculated using the GraphPad StatMate software program (La Jolla, CA, USA). The power analysis demonstrated that group sizes of n¼10 and n¼8 were necessary to detect a difference of 40% in the fluo-3 fluorescence measurements and to detect a difference of 10% in the mag-fluo-4 fluorescence measurements, respectively, with a statistical power of 0.8 at a significance level (a) of 0.05 (two-tailed). On the other hand, a group size of n¼4 was necessary to detect a difference of 40% between group means of slope conductance associated with the activation of the SOCE current in patch-clamp experiments. All data in the text and figures are presented as mean (95% confidence intervals), and the number of myocytes examined is indicated by n in the text and is shown in parentheses in the figures. Statistical comparisons (among multiple groups) were performed by the Kruskal-Wallis test, with post hoc analysis by Dunn's multiple comparison test, using the GraphPad Prism 5 software program. All statistical tests were two-tailed. A value of P,0.05 was considered statistically significant.
Results
Functional evidence for the presence of SOCE in mouse ventricular myocytes
In the first series of experiments, we examined whether SOCE is present in mouse ventricular myocytes by measuring the cytosolic Ca 2+ levels using fluo-3 fluorescence intensity.
As shown in Figure 2A , bath application of thapsigargin (5 mM) and angiotensin II (1 mM) during Ca 2+ -free superfusion induced a small but gradual elevation of cytosolic Ca 2+ levels (refer to Fig. 3A) . Subsequent exposure to On the other hand, as demonstrated in Figure 2B , without the addition of thapsigargin and angiotensin II, a similar abrupt elevation of cytosolic Ca 2+ was observed after the addition of 1. (referred to as the Ca 2+ paradox). 10 11 We then examined the effects of the combined application of thapsigargin (5 mM) and angiotensin II (1 mM) on the SR Ca 2+ levels during Ca 2+ -free superfusion using the (Fig. 3A) .
Inhibition of SOCE by sevoflurane
We then addressed the question of whether the cytosolic Ca 2+ elevation mediated through SOCE was affected by clinically used concentrations of sevoflurane. As depicted in Figure 4A , SOCE was markedly inhibited by sevoflurane at concentrations of ≥2%. This inhibitory action of sevoflurane was concentration-dependent with an IC 50 of 137 mM (which corresponds to 0.96%, Fig. 4B ). The cytosolic Ca 2+ levels were found to decrease significantly for the last 5 min of Ca 2+ -free superfusion in the presence of sevoflurane at concentrations of ≥2% (Fig. 4A ).
In the next series of experiments, we investigated the inhibitory action of sevoflurane on the SOCE activity by measuring whole-cell currents evoked by depleting the SR Ca 2+ stores by the combined application of 5 mM thapsigargin and 1 mM angiotensin II (similar to experiments for measuring fluo-3 fluorescence). As demonstrated in Figure 5A -C, the combined application of thapsigargin and angiotensin II activated the SOCE current, which was characterized by an almost linear I-V relationship with a reversal potential of 0 mV (Fig. 5C, b-a) and the sensitivity to inhibition by 20 mM 2-APB (Fig. 5C, b-c) . 4 31 We then examined the effects of sevoflurane on the SOCE current activated in a similar way, and found that the SOCE current was inhibited by 50% by 1% sevoflurane (Fig. 5D -F) and almost totally by 3% sevoflurane ( Fig. 5G-I ), in a completely reversible manner. As demonstrated in Figure 5J , sevoflurane inhibited the SOCE current in a concentration-dependent manner (IC 50 of 144 mM, which corresponds to 1.0%) with almost full inhibition occurring at concentrations of ≥3%.
Discussion
Previous studies have reported that while adult rat ventricular myocytes have SOCE, 22 mouse ventricular myocytes exhibit small or even null SOCE. 5 8 25 32 The present experiments using fluorescence imaging of cytosolic and intraluminal SR Ca 2+ levels and whole-cell patch-clamp recordings found the presence of SOCE activity in mouse ventricular myocytes (Figs 2-5) . Furthermore, our recent immunocytochemistry studies in mouse ventricular myocytes detected the expression of several TRPC isoforms (TRPC1, TRPC3, and TRPC4), 10 which are putative molecular components of SOCE channels. 2 -4 At present, it remains unknown what factor(s) contributes to these differences in the detection of SOCE in mouse ventricular myocytes between these studies. Possible explanations may be related to a difference in the mouse strain used (FVB/N or 129/ReJ mice were examined in previous studies, 5 8 25 32 while C57BL/6J mice were used in the present study) and/or differences in the experimental conditions and protocols for measuring the SOCE. 
lC 50 = 137 mM n H = 1.73
4.0 BJA of 2-APB and sevoflurane are also expected to be involved in their inhibitory actions on SOCE, in addition to their blocking actions on the SOCE channel itself (Figs 3-5) . It is well known that cellular Ca 2+ overload occurs during the early phase of reperfusion and leads to ischaemia/ reperfusion-induced myocardial injuries. 36 In recent years, experimental evidence has been presented to indicate that the SOCE pathway is an important contributor to Ca 2+ overload during ischaemia/reperfusion in the heart. 12 13 It is therefore reasonable to expect that the inhibitory action of sevoflurane on SOCE activity contributes at least partly to the attenuation of cellular Ca 2+ overload in ischaemia/reperfusion injuries in the heart. The SOCE activity was consistently accompanied by hypercontracture of ventricular myocytes under the present experimental conditions where the SR Ca 2+ store was depleted by pharmacological manipulation (Fig. 2A) . However, it still remains unknown as to which cellular event(s) happens during the activation of SOCE under in vivo conditions. Since our present experiments using isolated ventricular myocytes did not reproduce all of the features of SOCE activity in the whole heart, where SR Ca 2+ levels were affected by diverse factors such as metabolic status, electrical activity, and membrane receptor stimulation, future studies should examine the precise functional role of SOCE activity under various physiological and pathological conditions at tissue and organ levels.
In conclusion, the present study demonstrates that sevoflurane at concentrations of ≥2% inhibits SOCE-mediated Ca 2+ overload in mouse ventricular myocytes. These results raise the possibility that this inhibitory action of sevoflurane on SOCE is involved in its cardioprotective effect against ischaemia/reperfusion injury.
